A Case of Miliary Tuberculosis in a Patient with Behcet's Disease and Uveitis Receiving Infliximab.
10.4046/trd.2009.67.5.454
- Author:
Jung Wan YOO
1
;
Jae Hyung ROH
;
Jin Wook PARK
;
Yong Giun KIM
;
Ji Woong JANG
;
Soo Young NA
;
Tae Sun SHIM
Author Information
1. Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. shimts@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Tumor Necrosis Factor-alpha;
Infliximab;
Tuberculosis, Miliary
- MeSH:
Antibodies, Monoclonal;
Arthritis, Rheumatoid;
Crohn Disease;
Humans;
Military Personnel;
Opportunistic Infections;
Spondylitis, Ankylosing;
Stress, Psychological;
Tuberculosis;
Tuberculosis, Miliary;
Tumor Necrosis Factor-alpha;
Uveitis;
Infliximab
- From:Tuberculosis and Respiratory Diseases
2009;67(5):454-457
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Infliximab, a TNF-alpha antagonist, has been used to treat refractory rheumatoid arthritis, ankylosing spondylitis, Crohn's disease and Behcet's disease. Tuberculosis (TB) is a well-known opportunistic infection in patients receiving infliximab. Therefore, patients should be screened and treated for latent or active TB infection before being administered infliximab. Recently, we encountered a case of military TB during infliximab therapy in a patient suffering from Behcet's disease and uveitis. We report this case with a review of the relevant literature.
